Hemolysis in Blood Samples in the ER
Sponsor
University Hospital, Geneva (Other)
Overall Status
Completed
CT.gov ID
NCT01815931
Collaborator
(none)
2,800
1
4
698.6
Study Details
Study Description
Brief Summary
In this study, we aim to identify risk factors for hemolysis in blood samples drawn in the ED.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
2800 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Study Start Date
:
Jun 1, 2013
Actual Primary Completion Date
:
Oct 1, 2013
Actual Study Completion Date
:
Oct 1, 2013
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| ED patients
|
Outcome Measures
Primary Outcome Measures
- Hemolysis rate [1 day]
Eligibility Criteria
Criteria
Ages Eligible for Study:
16 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
16 years
Exclusion Criteria:
- In vivo hemolysis
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | University Hospital, Geneva | Geneva | GE | Switzerland | 1211 |
Sponsors and Collaborators
- University Hospital, Geneva
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Olivier T. Rutschmann,
MD, MPH,
University Hospital, Geneva
ClinicalTrials.gov Identifier:
NCT01815931
Other Study ID Numbers:
- SU-032013
First Posted:
Mar 21, 2013
Last Update Posted:
Nov 11, 2013
Last Verified:
Nov 1, 2013